Shares of Procaps Group S.A. (NASDAQ:PROC – Get Free Report) were down 40.3% during mid-day trading on Friday . The stock traded as low as $0.77 and last traded at $0.95. Approximately 658,169 shares changed hands during trading, an increase of 1,594% from the average daily volume of 38,864 shares. The stock had previously closed at $1.59.
Procaps Group Stock Performance
The firm has a 50 day simple moving average of $1.24 and a 200-day simple moving average of $1.68.
Institutional Investors Weigh In On Procaps Group
A hedge fund recently bought a new stake in Procaps Group stock. Itau Unibanco Holding S.A. bought a new position in shares of Procaps Group S.A. (NASDAQ:PROC – Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 177,974 shares of the company’s stock, valued at approximately $416,000. Itau Unibanco Holding S.A. owned about 0.16% of Procaps Group as of its most recent SEC filing.
About Procaps Group
Procaps Group SA develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and respiratory.
Featured Articles
- Five stocks we like better than Procaps Group
- Canada Bond Market Holiday: How to Invest and Trade
- How to Build the Ultimate Everything ETF Portfolio
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Dutch Bros or Starbucks: Which Coffee Stock Has More Growth?
- How to Invest in Biotech Stocks
- 3 Stocks With High ROE and Market-Beating Growth Potential
Receive News & Ratings for Procaps Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procaps Group and related companies with MarketBeat.com's FREE daily email newsletter.
